Luis
Montuenga Badía
Catedrático de Universidad
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublications in collaboration with researchers from Hospital Universitari de Bellvitge (8)
2023
-
IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer
Journal of Thoracic Oncology, Vol. 18, Núm. 5, pp. 564-575
2020
-
Comprehensive analysis of SWI/SNF inactivation in lung adenocarcinoma cell models
Cancers, Vol. 12, Núm. 12, pp. 1-14
-
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors
Annals of Oncology, Vol. 31, Núm. 2, pp. 274-282
-
The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non–Small Cell Lung Cancer
Journal of Thoracic Oncology, Vol. 15, Núm. 3, pp. 344-359
2019
-
YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib
American Journal of Respiratory and Critical Care Medicine, Vol. 200, Núm. 7, pp. 888-899
2018
-
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
The Lancet Respiratory Medicine, Vol. 6, Núm. 10, pp. 771-781
2017
-
Genomic profiling of patient-derived xenografts for lung cancer identifies B2M inactivation impairing immunorecognition
Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3203-3213
2014
-
MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1
Cancer Discovery, Vol. 4, Núm. 3, pp. 293-303